FDA libera Boostrix da GSK para uso durante a gravidez para prevenir coqueluche em recém-nascidos
Fonte: FirstWord Pharma (Texto original, publicado em inglês) FDA clears GSK’s Boostrix for use during pregnancy to prevent pertussis in newborns The FDA on Friday said it is allowing GlaxoSmithKline’s Boostrix (Tdap) vaccine to be given during the third trimester of pregnancy to prevent whooping cough in infants younger than two months old. Boostrix was